Drug Information Association Logo

DIA to Host One-Day Conference on Liability Risks in Clinical Trials

Horsham, PA, USA — Jan 20, 2010

The Drug Information Association (DIA) will host its first Liability Risks in Clinical Trial Conference on February 25, 2010 in Washington, DC.

Experienced lawyers from one of the premier pharmaceutical and medical device litigation defense firms in the country will present a special mock trial designed to explore legal issues surrounding clinical trials and sound strategies for dealing with them. Topics will include:

  • Government Enforcement in Clinical Trials
  • Litigation Update: What Can Happen with Clinical Trials
  • Avoiding Liability, Bad Documents. and Bad Press
  • Clinical Trials on Trial: Potential Legal Liability Arising from Clinical Trials (Mock Trial)

“Understanding the issues and managing them effectively go hand-in-hand in providing important safeguards against future criminal and civil liability,” says Program Committee Member Carol Poindexter, JD, Partner, Corporate Law Section, Shook Hardy & Bacon LLP. “This provocative one-day conference will bring together clinical research professionals, mid- and-senior level clinical project managers and decision makers, and regulatory and legal affairs professionals to discuss legal issues related to conducting clinical trials.

Register for Liability Risks in Clinical Trials.






ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.